Course Content
Endocrine & Reproductive System Module — 4th Year MBBS
AIM EXAM ARENA • KMU STYLE

KMU Past Paper Practice

Parathyroid Disorders: Hyperparathyroidism and Hypoparathyroidism
4th Year MBBS • 20 A-type Single Best Answer MCQs

MCQ 1

Question:

A 42-year-old patient has persistent hypercalcemia with an elevated PTH concentration. At neck exploration, all four parathyroid glands are enlarged rather than one gland being dominant. Which pathological process best explains this pattern?

Options:

Solitary parathyroid adenoma
Primary parathyroid hyperplasia
Autoimmune gland destruction
Postsurgical hypoparathyroidism
Functional PTH suppression
Correct Answer:
Primary parathyroid hyperplasia
Explanation: Primary hyperplasia typically involves multiple glands, whereas a parathyroid adenoma is usually a solitary lesion.

MCQ 2

Question:

A 36-year-old woman with chronic intestinal malabsorption has low serum calcium and a persistently elevated PTH concentration. Renal function is normal. Which disorder best explains this hormonal response?

Options:

Primary hypoparathyroidism
Tertiary hyperparathyroidism
Parathyroid carcinoma
Secondary hyperparathyroidism
Autonomous parathyroid adenoma
Correct Answer:
Secondary hyperparathyroidism
Explanation: Malabsorption and vitamin D deficiency can lower calcium and appropriately stimulate the parathyroid glands, producing secondary hyperparathyroidism.

MCQ 3

Question:

A 58-year-old patient with long-standing PTH excess develops diffuse bone pain and a fragility fracture. Bone tissue shows marked osteoclastic activity with replacement of marrow by fibrous tissue. Which skeletal lesion is most likely?

Options:

Osteitis fibrosa cystica
Osteomalacia
Osteomyelitis
Osteonecrosis
Osteochondroma
Correct Answer:
Osteitis fibrosa cystica
Explanation: Severe prolonged PTH excess increases bone resorption and may produce marrow fibrosis and weakened bone, termed osteitis fibrosa cystica.

MCQ 4

Question:

A patient with prolonged severe hyperparathyroidism develops an expansile skeletal lesion containing fibrous tissue, hemorrhage and giant cells. The lesion has a characteristic brown appearance. Which feature is mainly responsible for the color?

Options:

Calcium deposition within cartilage
Accumulation of parathyroid pigment
Necrosis of mineralized bone
Deposition of excess phosphate
Hemorrhage with hemosiderin deposition
Correct Answer:
Hemorrhage with hemosiderin deposition
Explanation: Brown tumors contain repeated hemorrhage and hemosiderin, which gives the lesion its brown appearance; they are reactive lesions rather than true tumors.

MCQ 5

Question:

A 55-year-old man with PTH-dependent hypercalcemia complains of intense thirst and passes large volumes of dilute urine. Which physiological disturbance best explains these symptoms?

Options:

Excess renal phosphate conservation
Increased glomerular protein filtration
Reduced renal concentrating ability
Increased renal glucose reabsorption
Reduced renal blood flow from low calcium
Correct Answer:
Reduced renal concentrating ability
Explanation: Hypercalcemia interferes with renal urine-concentrating ability, producing polyuria, volume loss and compensatory polydipsia.

MCQ 6

Question:

A 63-year-old woman has mild primary hyperparathyroidism discovered on routine testing. She has no renal calculi, significant skeletal involvement or troublesome symptoms and is not proceeding to surgery. Which management approach is most appropriate?

Options:

Immediate intravenous calcium therapy
Clinical and biochemical monitoring
Long-term phosphate supplementation
Routine active vitamin D replacement
Emergency parathyroid exploration
Correct Answer:
Clinical and biochemical monitoring
Explanation: Selected patients with mild uncomplicated primary hyperparathyroidism who do not undergo surgery can be followed with appropriate clinical and biochemical surveillance.

MCQ 7

Question:

A patient with severe symptomatic hypercalcemia has received appropriate intravenous fluid replacement. The physician wants an additional agent that can lower serum calcium relatively rapidly while longer-acting treatment takes effect. Which therapy is most suitable?

Options:

Oral calcium
Active vitamin D
Magnesium replacement
Phosphate supplementation
Calcitonin
Correct Answer:
Calcitonin
Explanation: Calcitonin provides a relatively rapid calcium-lowering effect and can be used as an early adjunct in severe hypercalcemia.

MCQ 8

Question:

A hospitalized patient with severe hypercalcemia receives fluids and a rapidly acting calcium-lowering agent. Additional treatment is required to provide a more sustained reduction in calcium while the underlying disorder is addressed. Which option best serves this purpose?

Options:

Longer-acting antiresorptive therapy
High-dose calcium replacement
Active vitamin D supplementation
Chronic magnesium administration
Oral phosphate alone
Correct Answer:
Longer-acting antiresorptive therapy
Explanation: Antiresorptive treatment can provide a more sustained calcium-lowering effect after initial rapid measures while definitive therapy is planned.

MCQ 9

Question:

A patient with chronic kidney disease has severe secondary hyperparathyroidism despite appropriate management of phosphate balance, vitamin D metabolism and other medical measures. PTH remains markedly elevated with progressive complications. What is the next major management principle?

Options:

Stop all biochemical monitoring
Start chronic intravenous calcium alone
Perform thyroid hormone suppression
Consider parathyroid surgery
Increase dietary phosphate intake
Correct Answer:
Consider parathyroid surgery
Explanation: Severe secondary hyperparathyroidism that remains uncontrolled despite appropriate medical therapy may require surgical management.

MCQ 10

Question:

A man with advanced renal failure has markedly elevated PTH and an increased serum phosphate concentration. In another patient with primary hyperparathyroidism, serum phosphate is reduced. Which factor best explains the high phosphate in the patient with renal failure?

Options:

Reduced intestinal calcium absorption alone
Increased parathyroid calcium sensitivity
Failure of diseased kidneys to excrete phosphate adequately
Loss of phosphate into the gastrointestinal tract
Suppression of PTH secretion by hypocalcemia
Correct Answer:
Failure of diseased kidneys to excrete phosphate adequately
Explanation: In chronic kidney disease, reduced renal phosphate excretion causes phosphate retention despite the phosphaturic action of elevated PTH.

MCQ 11

Question:

A patient develops persistent hypocalcemia and low PTH after neck surgery. Operative records indicate that the parathyroid glands were not intentionally removed. Which surgical event can still account for the hormonal deficiency?

Options:

Excess stimulation of chief cells
Increased renal vitamin D formation
Development of PTH receptor resistance
Autonomous multigland hyperplasia
Loss of parathyroid blood supply
Correct Answer:
Loss of parathyroid blood supply
Explanation: Postoperative hypoparathyroidism can result from devascularization of the glands even when they have not been physically removed.

MCQ 12

Question:

A 39-year-old patient with severe hypocalcemia develops painful carpopedal spasms followed by sudden difficulty breathing and inspiratory airway obstruction. Which complication should be recognized immediately?

Options:

Bronchial asthma
Laryngospasm
Pulmonary embolism
Pleural effusion
Pneumothorax
Correct Answer:
Laryngospasm
Explanation: Severe hypocalcemia increases neuromuscular excitability and can produce laryngospasm, which is an airway-threatening emergency.

MCQ 13

Question:

During examination of a patient with suspected hypocalcemia, tapping over the facial nerve just anterior to the ear produces twitching of the ipsilateral facial muscles. Which clinical sign has been demonstrated?

Options:

Trousseau sign
Hoffmann sign
Babinski sign
Chvostek sign
Kernig sign
Correct Answer:
Chvostek sign
Explanation: Chvostek sign is facial muscle contraction after tapping the facial nerve and reflects increased neuromuscular excitability in hypocalcemia.

MCQ 14

Question:

A teenager with hypoparathyroidism since early childhood is reviewed for chronic complications. Which finding is particularly associated with longstanding calcium disturbance beginning during development?

Options:

Dental abnormalities
Renal cortical tumor
Parathyroid adenoma
Splenic enlargement
Thyroid hyperplasia
Correct Answer:
Dental abnormalities
Explanation: Chronic hypocalcemia beginning early in life can interfere with normal dental development and produce characteristic dental abnormalities.

MCQ 15

Question:

A 45-year-old woman with poorly controlled chronic hypoparathyroidism reports progressive changes in her skin and nails. Which examination finding is most compatible with the chronic endocrine disorder?

Options:

Warm moist skin with soft nails
Marked skin pigmentation with clubbing
Dry coarse skin with brittle nails
Diffuse petechiae with nail hemorrhages
Generalized edema with cyanotic nails
Correct Answer:
Dry coarse skin with brittle nails
Explanation: Longstanding hypoparathyroidism may produce ectodermal changes, including dry skin, brittle nails and abnormalities of hair.

MCQ 16

Question:

Two patients have confirmed hypocalcemia. One has vitamin D deficiency with an appropriate compensatory endocrine response, while the other has failure of parathyroid function. Which laboratory finding most strongly identifies the patient with true hypoparathyroidism?

Options:

Elevated serum calcium
Markedly elevated PTH
Suppressed serum phosphate
Increased active vitamin D formation
Low or inappropriately normal PTH
Correct Answer:
Low or inappropriately normal PTH
Explanation: Hypocalcemia should stimulate PTH secretion. Failure of PTH to rise appropriately therefore indicates defective parathyroid function.

MCQ 17

Question:

A patient with chronic hypoparathyroidism continues to have difficult biochemical control despite carefully supervised conventional calcium and active vitamin D therapy. Which specialist treatment may be considered in selected cases?

Options:

Calcitonin replacement
PTH replacement therapy
Antiresorptive therapy alone
Calcimimetic therapy
Parathyroid suppression therapy
Correct Answer:
PTH replacement therapy
Explanation: PTH replacement may be considered in selected patients whose chronic hypoparathyroidism remains difficult to control with conventional treatment.

MCQ 18

Question:

A patient has an elevated PTH concentration but no clear evidence of autonomous hypercalcemia. Before labeling the condition as primary parathyroid disease, the physician wants to identify common physiological causes of secondary PTH elevation. Which combination is most useful?

Options:

ECG and chest radiography
Thyroid imaging and serum TSH
Parathyroid biopsy and neck CT
Renal function and vitamin D status
Brain imaging and serum magnesium alone
Correct Answer:
Renal function and vitamin D status
Explanation: Chronic kidney disease and vitamin D deficiency are important causes of secondary PTH elevation and should be considered during biochemical assessment.

MCQ 19

Question:

A patient with established primary hyperparathyroidism develops recurrent flank discomfort and microscopic hematuria. The clinician suspects renal complications of prolonged hypercalcemia. Which investigation best evaluates the suspected end-organ involvement?

Options:

Renal imaging
Parathyroid cytology
Brain CT scanning
Thyroid scintigraphy
Pituitary MRI
Correct Answer:
Renal imaging
Explanation: Renal imaging can demonstrate calculi or nephrocalcinosis and helps define renal end-organ involvement in hyperparathyroidism.

MCQ 20

Question:

A patient with chronic hypoparathyroidism is receiving long-term replacement therapy. The clinician explains that treatment should relieve hypocalcemic symptoms without creating avoidable renal complications. Which therapeutic goal best reflects this principle?

Options:

Maximize serum calcium regardless of urinary loss
Suppress calcium absorption to reduce phosphate
Maintain safe calcium while limiting excessive urinary calcium
Maintain persistent hypocalcemia to protect the kidney
Increase phosphate concentrations during replacement
Correct Answer:
Maintain safe calcium while limiting excessive urinary calcium
Explanation: Chronic treatment aims for adequate symptom control and safe calcium levels while avoiding excessive calcium replacement and hypercalciuria.
Scroll to Top
💬 WhatsApp Support